Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

marketbeat.com - aTyr Pharma, Inc. (NASDAQ:ATYR) Given Average Recommendation of 'Hold' by Brokerages
aTyr Pharma, Inc. (NASDAQ:ATYR) Given Average Recommendation of 'Hold' by Brokerages
MarketBeat

Shares of aTyr Pharma, Inc. (NASDAQ:ATYR - Get Free Report) have been assigned an average recommendation of 'Hold' from the seven research firms that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock…

wsj.com - Shomari Wills - Meet the Inventor Dubbed 'Black Edison,' Who Beat Thomas Edison in Court
Meet the Inventor Dubbed 'Black Edison,' Who Beat Thomas Edison in Court
Wall Street Journal

“USA250: The Story of the World's Greatest Economy” is a yearlong WSJ series examining America's first 250 years. Read more about it from Editor in Chief Emma Tucker. In the 1880s, a little-known figure arrived suddenly on the…

indianexpress.com - Dheeraj Mishra - To decongest, Cabinet clears Rs 24K-cr multi-tracking projects in UP, Andhra
To decongest, Cabinet clears Rs 24K-cr multi-tracking projects in UP, Andhra
The Indian Express

2 min read New Delhi Make us preferred source on Google In a bid to decongest parts of two key high-density routes of Indian Railways, the Cabinet Committee on Economic Affairs, chaired by PM Narendra Modi, on Saturday approved multiple-tracking of…

thehindubusinessline.com - War stress test reveals winners & losers in factor investing
War stress test reveals winners & losers in factor investing
BusinessLine

The US–Iran military escalation triggered a sharp risk-off phase across global markets, with crude oil prices surging, bond yields hardening, and concerns around global growth intensifying. Indian equities were no exception. Between February…

marketbeat.com - Growth Stocks Worth Watching - April 18th
Growth Stocks Worth Watching - April 18th
MarketBeat

Prologis Q1 2026: Data Centers Steal the Show Prologis, Teledyne Technologies, Ascendis Pharma A/S, Hamilton Lane, and Tyra Biosciences are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Growth stocks are…

thehindubusinessline.com - Lupin gets USFDA Form 483 with three observations for New Jersey facility
Lupin gets USFDA Form 483 with three observations for New Jersey facility
BusinessLine

Pharma major Lupin Ltd on Saturday said the US health regulator has issued Form 483 with three observations to its Somerset, New Jersey, facility in the US following an inspection. The USFDA has concluded the inspection at our manufacturing…

cyclingnews.com - Matilda Price - O Gran Camiño: Adam Yates seals overall victory as Pinarello wins atop Monte Trega
O Gran Camiño: Adam Yates seals overall victory as Pinarello wins atop Monte Trega
Cyclingnews

Adam Yates (UAE Team Emirates-XRG) sealed the overall victory on the final stage of O Gran Camiño, finishing third behind stage victor Alessandro Pinarello (NSN) on the steep slopes of the Alto Monte Santa Trega. Starting the day in the…

smh.com.au - Kishor Napier-Raman - Peptides promise a lot - but are they safe?
Peptides promise a lot - but are they safe?
The Sydney Morning Herald

You have reached your maximum number of saved items. Remove items from your saved list to add more. Last month, Max Marchione, the 25-year-old Australian founder of $300 million San Francisco health technology start-up Superpower squared off in a…

decrypt.co - Jose Antonio Lanz - OpenAI's New AI Model Rosalind Could Shave Years Off Drug Discovery. You Probably Can't Use It
OpenAI's New AI Model Rosalind Could Shave Years Off Drug Discovery. You Probably Can't Use It
Decrypt

OpenAI just named its first domain-specific AI model after Rosalind Franklin —the British chemist whose X-ray crystallography work helped reveal DNA's double helix, and who was famously denied credit for it during her lifetime. GPT-Rosalind…

thehindubusinessline.com - Nifty 50, Nifty 500: Dissecting the potential winners and losers amid war and volatility
Nifty 50, Nifty 500: Dissecting the potential winners and losers amid war and volatility
BusinessLine

The last five years in Indian equities can be seen in two distinct phases. In the first three-and-a-half years, Nifty 50 raced at a brisk pace of 18.7 per cent annual CAGR till September 2024. The Nifty 50 one-year forward PE gained 2 whole points…

marketbeat.com - Pharmaceutical Stocks To Follow Now - April 18th
Pharmaceutical Stocks To Follow Now - April 18th
MarketBeat

Nuclear, Pharma & Travel Buybacks: Confident or Cautious Signals? Eli Lilly and Company, AbbVie, Abbott Laboratories, Gilead Sciences, Pfizer, McKesson, and Bristol Myers Squibb are the seven Pharmaceutical stocks to watch today, according to…

marketbeat.com - AbbVie Inc. $ABBV Shares Sold by Berger Financial Group Inc
AbbVie Inc. $ABBV Shares Sold by Berger Financial Group Inc
MarketBeat

Berger Financial Group Inc cut its position in AbbVie Inc. (NYSE:ABBV - Free Report) by 24.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 15,097 shares of the company's stock after selling…

marketbeat.com - Eli Lilly and Company $LLY Shares Acquired by Border to Coast Pensions Partnership Ltd
Eli Lilly and Company $LLY Shares Acquired by Border to Coast Pensions Partnership Ltd
MarketBeat

Border to Coast Pensions Partnership Ltd lifted its holdings in Eli Lilly and Company (NYSE:LLY - Free Report) by 11.5% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 72,663 shares of…

marketbeat.com - Foster Victor Wealth Advisors LLC Purchases 1,127 Shares of Eli Lilly and Company $LLY
Foster Victor Wealth Advisors LLC Purchases 1,127 Shares of Eli Lilly and Company $LLY
MarketBeat

Foster Victor Wealth Advisors LLC lifted its position in shares of Eli Lilly and Company (NYSE:LLY - Free Report) by 94.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional…

marketbeat.com - Bingham Private Wealth LLC Purchases New Shares in Johnson & Johnson $JNJ
Bingham Private Wealth LLC Purchases New Shares in Johnson & Johnson $JNJ
MarketBeat

Bingham Private Wealth LLC purchased a new stake in shares of Johnson & Johnson (NYSE:JNJ - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 8,626 shares…

Receive a Daily briefing on Pharma Industry News

Get Started